Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

6.685 -0.035 (-0.52%)
Streaming Delayed Price Updated: 3:33 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,983,595
Open 6.800
Bid (Size) 6.680 (6,200)
Ask (Size) 6.690 (4,400)
Prev. Close 6.720
Today's Range 6.600 - 6.860
52wk Range 3.210 - 8.400
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026
Conference call scheduled for 4:30 p.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Receives New Patent for Tenapanor
New patent covers IBSRELA® and XPHOZAH® and expires in 2042 
From Ardelyx, Inc.
Via GlobeNewswire

Performance

YTD
+8.7%
+8.7%
1 Month
-13.9%
-13.9%
3 Month
+20.0%
+20.0%
6 Month
+11.6%
+11.6%
1 Year
+4.1%
+4.1%

More News

Read More
News headline image
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Stock Rises Premarket As Piper Sees Over 100% Upside — Says Constipation Drug ‘Stole The Show’ With 2026 Guidance ↗
Via Stocktwits
Ardelyx Stock Slips After-Hours As $100M Shelf Filing Sparks Dilution Fears After Strong Q3 ↗
Via Stocktwits
News headline image
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
From Equity Insider
Via GlobeNewswire
News headline image
Ardelyx Stock Is Rallying – What Is Making Retail So Bullish? ↗
Via Stocktwits
News headline image
Ardelyx Reports Preliminary 2025 Revenue and Provides 2026 Strategic Outlook
From Ardelyx, Inc.
Via GlobeNewswire
Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela ↗
Via Stocktwits
News headline image
Earnings Scheduled For October 30, 2025 ↗
Via Benzinga
News headline image
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
Via The Motley Fool
News headline image
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Insperity Posts Downbeat Q3 Results, Joins IAC, Archer-Daniels-Midland And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Why Upwork Shares Are Trading Higher By Over 22%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Top movers in Thursday's after hours session ↗
Via Chartmill
News headline image
Ardelyx Inc (NASDAQ:ARDX) Stock Surges on Q3 2025 Revenue Beat and Raised Guidance ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
From Ardelyx, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ardelyx, Inc. - Common Stock publicly traded?
Yes, Ardelyx, Inc. - Common Stock is publicly traded.
What exchange does Ardelyx, Inc. - Common Stock trade on?
Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ardelyx, Inc. - Common Stock?
The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
What is the current price of Ardelyx, Inc. - Common Stock?
The current price of Ardelyx, Inc. - Common Stock is 6.685
When was Ardelyx, Inc. - Common Stock last traded?
The last trade of Ardelyx, Inc. - Common Stock was at 02/19/26 03:33 PM ET
What is the market capitalization of Ardelyx, Inc. - Common Stock?
The market capitalization of Ardelyx, Inc. - Common Stock is 689.35M
How many shares of Ardelyx, Inc. - Common Stock are outstanding?
Ardelyx, Inc. - Common Stock has 689M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.